The U.S. Food and Drug Administration is announcing the first of a series of five public meetings to provide educational sessions for stakeholders who are interested in the new animal drug approval process.The U.S. Food and Drug Administration is announcing the first of a series of five public meetings to provide educational sessions for stakeholders who are interested in the new animal drug approval process.